Mike is an experienced Patent Attorney in the pharmaceutical field. He has worked in-house for a major pharmaceutical company and uses his experience to provide clients with robust, commercially focussed IP advice and patent protection.
Mike specialises in the pharmaceutical field and has considerable experience in due diligence evaluations, licence negotiations, patent term extensions, SPCs regulatory data exclusivity, patent listings, freedom to operate analysis, validity analysis and EPO oppositions and appeals.
He joined the patent profession in 1996 and prior to joining HGF worked for a number of drug development projects and marketed pharmaceutical products. Mike also worked on numerous major due diligence evaluations, involving in-licensing and acquisition of high value pharmaceutical products.
Mike joined HGF in 2013 and became a Partner in 2014. He uses his extensive in-house experience to provide commercially focused IP advice and to help his clients identify and protect their IP assets with robust patent protection.
Mike also focuses on the drafting and worldwide prosecution and defence of patents covering new chemical entities in a wide range of therapeutic areas including oncology, respiratory and infection, drug delivery, dosage regiments and methods of treatment.
He acts for a wide range of clients including multinationals, SMEs, universities and research organisations.